TRALI risk reduction: Donor and component management strategies

Journal of Clinical Apheresis

Volumn 24, Issue 3, 2009, Pages 122-129

  Eder, Anne F ^a   Benjamin, Richard J ^a  

^a AMERICAN RED CROSS BLOOD SERVICES   (United States)

Author keywords

HLA antibodies; TRALI; Transfusion reactions

Indexed keywords

HLA ANTIBODY; LEUKOCYTE ANTIBODY;

ALLOIMMUNIZATION; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CHILL; CLINICAL PRACTICE; DIAGNOSTIC PROCEDURE; DYSPNEA; FEVER; HUMAN; LUNG INFILTRATE; MEDICAL DECISION MAKING; MORBIDITY; MORTALITY; NONHUMAN; PLASMA VOLUME; RISK REDUCTION; STANDARD; THROMBOCYTOPHERESIS; TRANSFUSION RELATED ACUTE LUNG INJURY;

ACUTE DISEASE; ANIMALS; AUTOANTIBODIES; BLOOD BANKS; BLOOD COMPONENT TRANSFUSION; BLOOD DONORS; BLOOD PRESERVATION; DONOR SELECTION; FEMALE; HLA ANTIGENS; HUMANS; LUNG INJURY; MALE; PREGNANCY; RISK ADJUSTMENT;

EID: 67449147363     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20198     Document Type: Article

References (43)

1. Kleinman S, Caulfield T, Chan P, Davenport R, McFarland J, McPhedran S, Meade M, Morrison D, Pinsent T, Robillard P, Slinger P. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004; 44:1774-1789.
2. Kleinman S. A perspective on transfusion-related acute lung injury two years after the Canadian Consensus Conference. Transfusion 2006;46:1465-1468.
3. Toy P, Popovsky MA, Abraham E, Ambruso DR, Holness LG, Kopko PM, McFarland JG, Nathens AB, Silliman CC, Stroncek D, National Heart, Lung and Blood Institute Working Group on TRALI. Transfusion-related acute lung injury: definition and review. Crit Care Med 2005;33:721-726.
4. Andrzejewski C, Popovsky MA. Transfusion-associated adverse pulmonary sequelae: widening our perspective. Transfusion 2005; 45:1048-1050.
5. Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood 2005;105:2266-2273.
6. Silliman CC. The two-event model of transfusion-related acute lung injury. Crit Care Med 2006;34(5 Suppl):S124-S131.
7. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985;25:573-577.
8. Triulzi DJ. Transfusion-related acute lung injury: an update. Hematology Am Soc Hematol Educ Prog 2006:497-501.
9. Bux J. Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion. Vox Sang 2005;89:1-10.
10. AABB. Standards for Blood Banks and Transfusion Services, 24th ed., AABB Standard 5.4.21. Bethesda, MD: AABB; 2006.
11. AABB. Transfusion Related Acute Lung Injury, AABB Bulletin #05-06. Bethesda, MD: AABB; 2005.
12. AABB. Transfusion Related Acute Lung Injury, AABB Bulletin #06-07. Bethesda, MD: AABB; 2006.
13. Wendel S, Biagini S, Trigo F, Fontão-Wendel R, Taaning E, Jorgensen J, Riisom K, Krusius T, Koskinen S, Kretschmer V, Karger R, Lawlor E, Okazaki H, Charlewood R, Brand A, Solheim BG, Flesland O, Letowska M, Zupanska B, Muñiz-Diaz E, Nogués N, Senn M, Mansouri-Taleghani B, Chapman CE, Massey E, Navarrete C, Stainsby D, Win N, Williamson LM, Kleinman S, Kopko PM, Silva M, Shulman I, Holness L, Epstein JS. Measures to prevent TRALI. Vox Sang 2007;92:258-277.
14. Kopko P, Silva M, Shulman I, Kleinman S. AABB survey of transfusion-related acute lung injury policies and practices in the United States. Transfusion 2007;47:1679-1685.
15. Su L, Kamel H. How do we investigate and manage donors associated with a suspected case of transfusion-related acute lung injury. Transfusion 2007;47:1118-1124.
16. Eder AF, Herron R, Strupp A, Dy B, Notari EP, Chambers LA, Dodd RY, Benjamin RJ. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion 2007;47:599-607.
17. Kopko PM, Popovsky MA, MacKenzie MR, Paglieroni TG, Muto KN, Holland PV. HLA class II antibodies in transfusion-related acute lung injury. Transfusion 2001;41:1244-1248.
18. Davoren A, Curtis BR, Shulman IA, Mohrbacher AF, Bux J, Kwiatkowska BJ, McFarland JG, Aster RH. TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of two fatalities. Transfusion 2003;43:641-645.
19. Kao GS, Wood IG, Dorfman DM, Milford EL, Benjamin RJ. Investigations into the role of anti-HLA class II antibodies in TRALI. Transfusion 2003;43:185-191.
20. Looney MR, Su X, Van Ziffle JA, Lowell CA, Matthay MA. Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest 2006;116:1615-1623.
21. Looney MR, Matthay MA. Animal models of transfusion-related acute lung injury. Crit Care Med 2006;34(5 Suppl):S132-S136.
22. Rana R, Fernández-Pérez ER, Khan SA, Rana S, Winters JL, Lesnick TG, Moore SB, Gajie O. Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion 2006;46:1478-1483.
23. Gajic O, Rana R, Mendez JL, Rickman OB, Lymp JF, Hubmayr RD, Moore SB. Acute lung injury after blood transfusion in mechanically ventilated patients. Transfusion 2004;44:1468-1474.
24. Kopko PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA 2002;287:1968-1971.
25. Cooling L. Transfusion-related acute lung injury. JAMA 2002; 288:315-316.
26. Fadeyi EA, De Los Angeles Muniz M, Wayne AS, Klein HG, Leitman SF, Stroncek DF. The transfusion of neutrophil-specific antibodies causes leukopenia and a broad spectrum of pulmonary reactions. Transfusion 2007;47:545-550.
27. Nicolle AL, Chapman CE, Carter V, Wallis JP. Transfusion-related acute lung injury caused by two donors with anti-human leucocyte antigen class II antibodies: a look-back investigation. Transfus Med 2004;14:225-230.
28. Toy P, Hollis-Perry KM, Jun J, Nakagawa M. Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion-related acute lung injury. Transfusion 2004;44:1683-1688.
29. Win N, Ranasinghe E, Lucas G. Transfusion-related acute lung injury: a 5-year look-back study. Transfus Med 2002;12:387-389.
30. Zupanska B, Uhrynowska M, Michur H, Maslanka K, Zajko M. Transfusion-related acute lung injury and leucocyte-reacting antibodies. Vox Sang 2007;93:70-77.
31. Densmore TL, Goodnough LT, Ali S, Dynis M, Chaplin H. Prevalence of HLA sensitization in female apheresis donors. Transfusion 1999;39:103-106.
32. Triulzi DJ, Kakaiya R, Schreiber G. Donor risk factors for white blood cell antibodies associated with transfusion-associated acute lung injury: REDS-II leukocyte antibody prevalence study (LAPS). Transfusion 2007;47:563-564.
33. Triulzi D, Kakaiya R, Kleinman S, Busch MP, Norris P, Steele W, Hillyer CD, Schreiber GB. Relationship of HLA antibodies in blood donors to pregnancy and transfusion history. Transfusion 2007;47:P4-030A.
34. Aubuchon JP, Whitaker BI. America finds hemovigilance! Transfusion 2007;47:1937-1942.
35. Webert KE, Blajchman MA. Transfusion-related acute lung injury. Transfus Med Rev 2003;17:252-262.
36. Stroncek DF, Fadeyi E, Adams S. Leukocyte antigen and antibody detection assays: tools for assessing and preventing pulmonary transfusion reactions. Transfus Med Rev 2007;21: 273-286.
37. Yang X, Ahmed S, Chandrasekaran V. Transfusion-related acute lung injury resulting from designated blood transfusion between mother and child. Am J Clin Pathol 2004;121:590-592.
38. Serious Hazards of Transfusion Steering Group, Serious Hazards of Transfusion (SHOT), Annual Report, 2004. Available at http://www.shotuk.org/SHOT%20REPORT%202004.pdf. Accessed on July 4th, 2006.
39. Sebok MA, Benjamin RJ, Eder AF. Trends in the Utilization of Plasma Frozen Within 24 hours and Fresh Frozen Plasma, AABB Annual Meeting. Anaheim, CA: AABB; 2007.
40. Eder AF, Sebok MA. Plasma Components. Immunohematology 2007;23:150-157.
41. Rizk A, Gorson KC, Kenney L, Weinstein R. Transfusion-related acute lung injury after the infusion of IVIG. Transfusion 2001;41:264-268.
42. Suassuna JH, da Costa MA, Faria RA, Melichar AC. Noncardiogenic pulmonary edema triggered by intravenous immunoglobulin in cancer-associated thrombotic thrombocytopenic purpurahemolytic uremic syndrome. Nephron 1997;77:368-370.
43. O'Riordan T, Cameron J. Interpreting the Precautionary Principle. London: Earthscan Publications Ltd; 1994.